The University of Chicago Header Logo

Connection

Namrata Setia to Adenocarcinoma

Back to Details
This is a "connection" page, showing publications Namrata Setia has written about Adenocarcinoma.
Namrata Setia
Connection Strength
2.620
Adenocarcinoma
  1. Diagnostic Challenges due to a Germline Missense MSH2 Variant in a Patient With Immunotherapy-Responsive Locally Advanced Rectal Adenocarcinoma. Cancer Rep (Hoboken). 2024 Dec; 7(12):e70037.
    View in: PubMed
    Score: 0.572
  2. Next-generation sequencing identifies 2 genomically distinct groups among pyloric gland adenomas. Hum Pathol. 2020 03; 97:103-111.
    View in: PubMed
    Score: 0.404
  3. Predictive value of WHO classification for PD-L1 and Her2/Neu expression and distinct associations with protein expression based classification in gastric carcinoma. Hum Pathol. 2019 12; 94:64-70.
    View in: PubMed
    Score: 0.402
  4. Targeted mutational analysis of inflammatory bowel disease-associated colorectal cancers. Hum Pathol. 2019 07; 89:44-50.
    View in: PubMed
    Score: 0.389
  5. Measuring the Submucosal Depth of Invasion in Endoscopic Mucosal Resections for Barrett-associated Adenocarcinoma: Practical Issues and Relevance for the Decision for Esophagectomy. Arch Pathol Lab Med. 2022 11 01; 146(11):1338-1344.
    View in: PubMed
    Score: 0.124
  6. Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease. Cancer Discov. 2021 02; 11(2):308-325.
    View in: PubMed
    Score: 0.108
  7. Clinicopathological features of pyloric gland adenomas of the duodenum: a multicentre study of 57 cases. Histopathology. 2020 Feb; 76(3):404-410.
    View in: PubMed
    Score: 0.101
  8. Histologic and Outcome Study Supports Reclassifying Appendiceal Goblet Cell Carcinoids as Goblet Cell Adenocarcinomas, and Grading and Staging Similarly to Colonic Adenocarcinomas. Am J Surg Pathol. 2018 07; 42(7):898-910.
    View in: PubMed
    Score: 0.092
  9. Colorectal Carcinomas With Isolated Loss of PMS2 Staining by Immunohistochemistry. Arch Pathol Lab Med. 2018 Apr; 142(4):523-528.
    View in: PubMed
    Score: 0.089
  10. High-throughput Protein and mRNA Expression-based Classification of Gastric Cancers Can Identify Clinically Distinct Subtypes, Concordant With Recent Molecular Classifications. Am J Surg Pathol. 2017 01; 41(1):106-115.
    View in: PubMed
    Score: 0.083
  11. Familial Gastric Cancers. Oncologist. 2015 Dec; 20(12):1365-77.
    View in: PubMed
    Score: 0.076
  12. Predictors of Lymph Node Metastasis in Western Early Gastric Cancer. J Gastrointest Surg. 2016 Mar; 20(3):531-8.
    View in: PubMed
    Score: 0.076
  13. Esophageal squamous cell carcinoma with pagetoid spread: a clinicopathologic study. Virchows Arch. 2025 Feb; 486(2):313-322.
    View in: PubMed
    Score: 0.034
  14. Evaluation of the Association of Perioperative UGT1A1 Genotype-Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical Trial. JAMA Netw Open. 2020 02 05; 3(2):e1921290.
    View in: PubMed
    Score: 0.026
  15. Gastric pyloric gland adenoma: a multicentre clinicopathological study of 67 cases. Histopathology. 2018 May; 72(6):1007-1014.
    View in: PubMed
    Score: 0.022
  16. Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma. Cancer Discov. 2018 01; 8(1):37-48.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.